News|Articles|August 21, 2024
Tufts CSDD Site Experience Survey
The Tufts Center for the Study of Drug Development (Tufts CSDD) is conducting a study on investigative site perspectives and burden associated with Direct-to-Patient (DTP) shipment of study treatments and supplies.
Advertisement
Researchers at Tufts CSDD at the Tufts University School of Medicine, in collaboration with Global Clinical Supplies Group (GCSG), a professional organization of global clinical supplies professionals, are conducting an academic survey to increase understanding of investigative site personnel experiences with the shipment of Investigational Products/Study Treatments to trial participants at their homes—also known as Direct-to-Patient (DtP) shipments of study drug. Your feedback is invaluable in helping to identify pain points and improvement areas.
Please take a few minutes to take survey. In appreciation for your participation, the Tufts CSDD research team will share with you a summary of results when the research concludes. Start the survey: https://tufts.qualtrics.com/jfe/form/SV_2bm7lW1vt6zl53g
Thank you in advance for your participation in this important research effort!
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement